These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12884254)

  • 1. Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer.
    Thanos CG; Liu Z; Goddard M; Reineke J; Bailey N; Cross M; Burrill R; Mathiowitz E
    J Pharm Sci; 2003 Aug; 92(8):1677-89. PubMed ID: 12884254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving relative bioavailability of dicumarol by reducing particle size and adding the adhesive poly(fumaric-co-sebacic) anhydride.
    Thanos CG; Liu Z; Reineke J; Edwards E; Mathiowitz E
    Pharm Res; 2003 Jul; 20(7):1093-100. PubMed ID: 12880296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(fumaric-co-sebacic) microspheres as oral drug delivery systems.
    Chickering D; Jacob J; Mathiowitz E
    Biotechnol Bioeng; 1996 Oct; 52(1):96-101. PubMed ID: 18629855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of multiple-unit floating-bioadhesive cooperative minitablets for improving the oral bioavailability of famotidine in rats.
    Zhu X; Qi X; Wu Z; Zhang Z; Xing J; Li X
    Drug Deliv; 2014 Sep; 21(6):459-66. PubMed ID: 24456044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential.
    Kockisch S; Rees GD; Young SA; Tsibouklis J; Smart JD
    J Pharm Sci; 2003 Aug; 92(8):1614-23. PubMed ID: 12884248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system.
    Dannenfelser RM; He H; Joshi Y; Bateman S; Serajuddin AT
    J Pharm Sci; 2004 May; 93(5):1165-75. PubMed ID: 15067693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on drug-milk freeze-dried formulations. I: Bioavailability of sulfamethizole and dicumarol formulations.
    Macheras PE; Reppas CI
    J Pharm Sci; 1986 Jul; 75(7):692-6. PubMed ID: 2428969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supersaturated polymeric micelles for oral cyclosporine A delivery.
    Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading.
    Shen H; Banerjee AA; Mlynarska P; Hautman M; Hong S; Kapetanovic IM; Lyubimov AV; Liu Y
    J Pharm Sci; 2012 Oct; 101(10):3877-85. PubMed ID: 22821759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delivery of insulin loaded poly(fumaric-co-sebacic) anhydride microspheres.
    Furtado S; Abramson D; Burrill R; Olivier G; Gourd C; Bubbers E; Mathiowitz E
    Int J Pharm; 2008 Jan; 347(1-2):149-55. PubMed ID: 17707601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
    Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model.
    Sensoy D; Cevher E; Sarici A; Yilmaz M; Ozdamar A; Bergişadi N
    Eur J Pharm Biopharm; 2009 Aug; 72(3):487-95. PubMed ID: 19223014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of oral bioavailability enhancing formulations during drug discovery.
    Zheng W; Jain A; Papoutsakis D; Dannenfelser RM; Panicucci R; Garad S
    Drug Dev Ind Pharm; 2012 Feb; 38(2):235-47. PubMed ID: 21851310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
    Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
    Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo, in vitro evaluation of linseed mucilage based buccal mucoadhesive microspheres of venlafaxine.
    Nerkar PP; Gattani S
    Drug Deliv; 2011 Feb; 18(2):111-21. PubMed ID: 20954808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats.
    Furtado S; Abramson D; Simhkay L; Wobbekind D; Mathiowitz E
    Eur J Pharm Biopharm; 2006 Jun; 63(2):229-36. PubMed ID: 16682174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.